NYSE:CVSHealthcare
CVS Health (CVS) Could Be 15% Undervalued As Earnings Beat And Guidance Rises
CVS Health (CVS) is back in focus after second quarter results topped revenue and profit expectations, full year earnings guidance was raised, and a revamped GLP 1 weight management program was announced.
See our latest analysis for CVS Health.
At a share price of US$97.16, CVS Health has seen a 1-day share price return of 2.28% and a year-to-date share price return of 21.25%. The 1-year total shareholder return of 46.13% and 3-year total shareholder return of 63.07% point to gains that...